The 2023 conference explored the myriad ways that biotechnology can influence and be influenced by biology. The conference featured industry and research leaders in prosthetics, wearable devices, artificial organs, computational modeling, and more! Speakers and workshop leaders represented innovative companies like Google Health, AtomicAI, and Ceribel, as well as top biotech VC firms like Tau Ventures, Amino Capital, and R42. The conference also featured many of Stanford’s experts in these fields!

The 2021 conference focused on how the biodesign innovation process of needs finding and product realization could be applied to address health inequities and promote global access to healthcare. The virtual conference featured a variety of topics, from racial and socioeconomic disparities in healthcare access to reducing pathogen transmission in under-resourced settings to building low-cost biomedical devices.

The 2019 conference focused on the medical device development pathway, from identifying unmet clinical needs to FDA clearance and patient translation. With representatives from Stanford Byers Center for Biodesign, UCSF, Medtronic, and more, Stanford students and members of the Bay Area community learned about the medtech industry from the perspective of venture capital, intellectual property, insurance reimbursement, engineering, and clinical testing.

The 2018 conference focused on personalized medicine from the perspective of research, industry, and public policy. Speakers from Stanford School of Medicine, Harvard Medical School, UCSF, Chan Zuckerberg Initiative, NIH All of Us, and more presented future directions on the field of predictive and precision medicine.